Neogenomics Laboratories

NeoGenomics News

NeoNEWS 8/12/2026

August 12, 2026

NPM1 MRD Analysis Name Change

As part of our ongoing commitment to providing clear and clinically meaningful diagnostic solutions, the NPM1 MRD Analysis will be renamed NPM1 Quantitative Analysis, effective August 30, 2026 to better reflect the test's intended use.


This update reflects a change in test name only. There are no changes to the assay, testing methodology, ordering workflow, or reporting. You can continue to order and utilize the test as you do today.


We remain committed to delivering high-quality molecular testing and appreciate your continued partnership. Please contact your NeoGenomics Sales Representative or Client Services team with any questions regarding this update.

Requirement: Two Patient Identifiers on Smears and Tubes


To support CAP compliance and ensure accurate specimen identification, all client-submitted peripheral blood (PB) or bone marrow (BM) smears and tubes must include two patient identifiers. In addition, when submitting hematology smears, the specimen source should be clearly indicated on the test requisition form and tubes and is highly recommended to be added to the smears.


Clear and complete labeling helps prevent testing delays, reduces the need for follow-up clarification, and ensures timely processing of patient samples. Over the coming months, updated submission materials and requisition forms will be released to help support this requirement and streamline the submission process.


For more information or questions, please contact our Client Services team at Client.Services@NeoGenomics.com or call 866.776.5907, option 3.


c-MET CDx IHC for NSCLC

Our c-MET CDx IHC assay for NSCLC at NeoGenomics provides detailed evaluation of MET protein expression, helping clinicians determine which patients may respond to an innovative targeted therapy.

Visit our webpage to see how HGF Receptor (c-Met) testing can enhance your approach to lung cancer care.
For a complete list of recent test updates, click here for a downloadable document to view the impacted interface test codes.



You have exceeded the maximum number of log in attempts and your account has been locked. Please click on Forgot Password to proceed or contact Client Services at 1-866-776-5907, option 3 for assistance. Thank You.